Literature DB >> 464191

Epidemic dengue hemorrhagic fever in rural Indonesia. I. Virological and epidemiological studies.

D J Gubler, W Suharyono, I Lubis, S Eram, J Sulianti Saroso.   

Abstract

Virological studies were carried out during an epidemic of dengue hemorrhagic fever in Central Java, Indonesia in 1976. Dengue virus was isolated from the acute sera of 45 of 69 patients (65%). The isolation rate was higher in primary than secondary cases. Dengue 3 was the predominant serotype being transmitted (27 isolates), but both dengue 1 (8 isolates) and dengue 4 (10 isolates) were also being transmitted. A composite picture of magnitude and duration of viremia showed that many patients were circulating over 10(8) MID50 per milliliter dengue 3 virus for the first 3 days of illness and that viremia persisted for 5-6 days in some persons. If all shock cases were considered, there was no relationship between dengue serotype and severity of disease. All three confirmed fatal cases, however, were associated with dengue type 3 infections.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 464191

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  16 in total

1.  Comparison of the mosquito inoculation technique and quantitative real time polymerase chain reaction to measure dengue virus concentration.

Authors:  Milly M Choy; Brett R Ellis; Esther M Ellis; Duane J Gubler
Journal:  Am J Trop Med Hyg       Date:  2013-09-09       Impact factor: 2.345

Review 2.  The dengue viruses.

Authors:  E A Henchal; J R Putnak
Journal:  Clin Microbiol Rev       Date:  1990-10       Impact factor: 26.132

3.  Genetic and biological differentiation of dengue 3 isolates obtained from clinical cases in Java, Indonesia, 1976-1978.

Authors:  E Lee; D J Gubler; R C Weir; L Dalgarno
Journal:  Arch Virol       Date:  1993       Impact factor: 2.574

4.  Viraemia in patients with naturally acquired dengue infection.

Authors:  D J Gubler; W Suharyono; R Tan; M Abidin; A Sie
Journal:  Bull World Health Organ       Date:  1981       Impact factor: 9.408

5.  Hospital-based prevalence of malaria and dengue in febrile patients in Bangladesh.

Authors:  Labib I Faruque; Rashid Uz Zaman; A S M Alamgir; Emily S Gurley; Rashidul Haque; Mahmudur Rahman; Stephen P Luby
Journal:  Am J Trop Med Hyg       Date:  2012-01       Impact factor: 2.345

6.  Dengue virus-elicited tryptase induces endothelial permeability and shock.

Authors:  Abhay Ps Rathore; Chinmay Kumar Mantri; Siti Ab Aman; Ayesa Syenina; Justin Ooi; Cyril J Jagaraj; Chi Ching Goh; Hasitha Tissera; Annelies Wilder-Smith; Lai Guan Ng; Duane J Gubler; Ashley L St John
Journal:  J Clin Invest       Date:  2019-07-02       Impact factor: 14.808

7.  Host and viral features of human dengue cases shape the population of infected and infectious Aedes aegypti mosquitoes.

Authors:  Minh Nguyen Nguyet; Thi Hue Kien Duong; Vu Tuan Trung; Than Ha Quyen Nguyen; Chau N B Tran; Vo Thi Long; Le Thi Dui; Hoa Lan Nguyen; Jeremy J Farrar; Edward C Holmes; Maia A Rabaa; Juliet E Bryant; Truong Thanh Nguyen; Huong Thi Cam Nguyen; Lan Thi Hong Nguyen; Mai Phuong Pham; Hung The Nguyen; Tai Thi Hue Luong; Bridget Wills; Chau Van Vinh Nguyen; Marcel Wolbers; Cameron P Simmons
Journal:  Proc Natl Acad Sci U S A       Date:  2013-05-14       Impact factor: 11.205

8.  Molecular mechanism of pathogenesis of dengue virus: Entry and fusion with target cell.

Authors:  S K Jain
Journal:  Indian J Clin Biochem       Date:  2005-07

9.  Clinical, virological and epidemiological characterization of dengue outbreak in Myanmar, 2015.

Authors:  A K Kyaw; M M Ngwe Tun; M L Moi; T Nabeshima; K T Soe; S M Thwe; A A Myint; K T T Maung; W Aung; D Hayasaka; C C Buerano; K Z Thant; K Morita
Journal:  Epidemiol Infect       Date:  2017-04-17       Impact factor: 4.434

10.  Emergence and global spread of a dengue serotype 3, subtype III virus.

Authors:  William B Messer; Duane J Gubler; Eva Harris; Kamalanayani Sivananthan; Aravinda M de Silva
Journal:  Emerg Infect Dis       Date:  2003-07       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.